Home

AbbVie Inc. - Financial Overview

Ticker - ABBV

Close PriceMarket CapP/E RatioForward P/E RatioImplied Growth*Implied Forward Growth*P/B Ratio
$189.83$335.32B81.115.627.8%9.1%236.1

Revenue and Net Income Chart EPS Chart
  Date Revenue Net Income EPS Revenue Change Net Income Change EPS Change
0 2021-12-31 $56.2B $11.5B $6.53 N/A N/A N/A
1 2022-12-31 $58.1B $11.8B $6.69 3.3% 2.5% 2.5%
2 2023-12-31 $54.3B $4.9B $2.75 -6.4% -58.9% -58.8%
3 2024-12-31 $56.3B $4.3B $2.40 3.7% -12.0% -12.8%
4 TTM 2025-03-31 $57.4B $4.2B $2.34 1.8% -1.9% -2.5%
5 Average 0.6% -17.6% -17.9%



ABBV - Forecast Data

Revenue and Net Income Forecast Chart
EPS Forecast Chart


ABBV - Y/Y % Change

Revenue Year-over-Year Change Chart
EPS Year-over-Year Change Chart
YoY Growth Rates

ABBV Year-over-Year Growth

  2021 2022 2023 2024 2025 2026 Average
Revenue Growth (%) 3.3% -6.4% 3.7% 6.6% 8.2% 3.1%
Revenue Analysts (#) 0 0 0 0 7 7
EPS Growth (%) 2.5% -58.9% -12.0% 407.0% 14.4% 70.6%
EPS Analysts (#) 0 0 0 0 7 7
  Metric Value
0 Total Assets $136,165M
1 Cash $5,175M
2 Total Liabilities $134,703M
3 Total Debt $69,889M
4 Total Equity $1,420M
5 Debt to Equity Ratio 49.22
ABBV Balance Sheet Chart


ABBV - Expense Overview

Revenue vs Expense Chart
Expense % of Revenue Chart
No data available
Year Revenue Change Cost of Revenue Change R&D Change Sales and Marketing Change General and Administrative Change SG&A Change
2021
2022 3.3% -0.2%
2023 -6.4% 17.2%
2024 3.7% -17.2%


ABBV - Unmapped Expense Line Items

No unmapped expenses.


ABBV - Valuation Chart


Valuation Chart

Share Price Treasury Yield Estimates Fair Value (P/E) Fair Value (P/S) Current P/S Current P/E
$189.83 4.5% Nicks Growth: N/A
Nick's Expected Margin: N/A
FINVIZ Growth: 15%		 Nicks: 6
Finviz: 28		 Nick's: 0.000 5.8 81.1
Basis Year Nicks Valuation Nicks vs Share Price Finviz Valuation Finviz vs Share Price
$2.34 EPS TTM $14.75 -92.2% $64.73 -65.9%
$12.28 EPS 2025 $77.41 -59.2% $339.68 78.9%
$14.05 EPS 2026 $88.56 -53.3% $388.64 104.7%